← Back to Clinical Trials
Recruiting NCT07101731

NCT07101731 Effects of Hypopressive Exercises on Urinary Incontinence and Erectile Dysfunction After Radical Prostatectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07101731
Status Recruiting
Phase
Sponsor Bartın Unıversity
Condition Prostate Cancer (Post Prostatectomy)
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-06-01
Primary Completion 2025-11-15

Eligibility & Interventions

Sex Male only
Min Age 55 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Pelvic Floor Muscle Training (PFMT)Hypopressive Exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-06-01 with a primary completion date of 2025-11-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial investigates the effects of hypopressive exercises on urinary incontinence and erectile dysfunction in men following radical prostatectomy. Participants will be randomly assigned to one of two groups: a control group receiving home-based pelvic floor muscle exercises and an experimental group receiving both pelvic floor muscle exercises and supervised hypopressive exercises twice per week. The study aims to determine whether the addition of hypopressive techniques, which target coordinated activation of the pelvic floor and abdominal muscles without increasing intra-abdominal pressure, offers greater improvements in urinary and sexual function. Primary outcomes include pelvic floor muscle strength and endurance, while secondary outcomes include urinary incontinence severity, erectile function, and quality of life.

Eligibility Criteria

Inclusion Criteria * Male individuals diagnosed with prostate cancer who have undergone radical prostatectomy * Experiencing both urinary incontinence and erectile dysfunction * Age \> 55 years * A score of 24 or higher on the Mini-Mental State Examination (MMSE) * Literate (able to read and write) * Willingness to participate in the study (signed informed consent) * Ability to voluntarily contract pelvic floor muscles * Ability to cooperate with the assessments and interventions used in the study Exclusion Criteria * History of urinary incontinence before surgery * Congenital abnormalities of the urinary system * Presence of neurological disorders * History of transurethral resection of the prostate (TURP) * Diagnosis of chronic obstructive pulmonary disease (COPD) and/or chronic restrictive pulmonary disease * History of inguinal hernia * Previous or current history of radiation therapy * Surgical or postoperative complications that prevent early physiotherapy intervention (e.g., urinary tract infection, bladder neck stenosis)

Contact & Investigator

Central Contact

Betül Erbay, M.Sc.

✉ fztbetulerbay@gmail.com

📞 +905072650111

Frequently Asked Questions

Who can join the NCT07101731 clinical trial?

This trial is open to male participants only, aged 55 Years or older, studying Prostate Cancer (Post Prostatectomy). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07101731 currently recruiting?

Yes, NCT07101731 is actively recruiting participants. Contact the research team at fztbetulerbay@gmail.com for enrollment information.

Where is the NCT07101731 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT07101731 clinical trial?

NCT07101731 is sponsored by Bartın Unıversity. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology